Media formats available:
Recommended
- The Imminent danger of Lp(a): Time to face to challengePrevalence and relevance of elevated Lp(a) in familial hypercholesterolemia
Prof. Børge Nordestgaard, MD
- The Imminent danger of Lp(a): Time to face to challengeLp(a) apheresis and CVD risk modulation
Elisa Waldmann, MD
- The Imminent danger of Lp(a): Time to face to challengeLDL vs Lp(a) cholesterol: confounding
Calvin Yeang, MD, PhD
- The Imminent danger of Lp(a): Time to face to challengeEntry of Lp(a) into the CV arena
Prof. Florian Kronenberg, MD